Of Europeans researchers Child-Innovac program, a pilot franaise Inserm team are working on a vacci

Home Editorial Society Sports Culture Internet Economy Discovery Health People Portraits The Other Afrik communiqus Readers Life Media News Topics Surveys Records Map of africa Archives Pan Africa North Africa> Algeria Egypt Libya Morocco Tunisia Western Sahara Africa West> Benin Burkina Faso Cape Verde Côte d'Ivoire aneurysm Gambia Ghana Guinea Guinea-Bissau aneurysm Liberia Mali Mauritania Niger Nigeria Senegal Sierra Leone Togo East Africa> Djibouti Eritrea aneurysm Ethiopia Kenya Somalia Sudan Uganda Tanzania South Sudan Central Africa> Angola Burundi Cameroon Central African Republic aneurysm Congo Gabon Equatorial Guinea DRC Rwanda Sao Tome and Chad principle Southern Africa> South Africa Mauritius Botswana Comoros Lesotho Madagascar Malawi Mozambique Namibia Reunion Seychelles Swaziland Zambia Zimbabwe France Caribbean World> Belgium Brazil Canada China Spain USA Great Britain Japan International Country Netherlands Switzerland UK Media Image of the Day E-mail Select blogs Call cheaper Boutik Proverbs Weather Travel Dating Afrik football Beauties Afrik Afrik kitchen AfrikEco Afrik TV Blogs Jobs Featured Afrik Concerts aneurysm Exhibitions Theatre Evenings rooms / seminars Movies Other Submit an Event
Of Europeans researchers Child-Innovac program, a pilot franaise Inserm team are working on a vaccine against pertussis, administered nasally that could protect aneurysm the babies less six months with a single dose.
Originally about 300,000 dcs every year in the world, ESPECIALLY in infants too young to be immuniss current vaccines, pertussis is a respiratory disease of Bactrian origin resulting in fits of violent aneurysm coughing. It continues to affect tens of millions of people.
Of Europeans researchers Child-Innovac aneurysm program pilot by franaise team INSERM, working on a manageable nasal path that could protect the babies under six months vaccine with a single dose. According to a Pre-Trial study published Wednesday in the journal Plos One online, this vaccine t test with success in humans.
Vaccines exist ncessitent three injections in total, mostly complete 2, 3 and 4 months. This in order to achieve optimal protection from 6 months. Researchers and concentrs two major respiratory pathognes such as Bordetella pertussis (whooping cough dclenchant Bactria) and respiratory syncytial virus (dclenchant bronchiolitis in infants). These pathognes reach mainly malnourished children protgs by currently available vaccines.
The new vaccine is composed of a living Bactria, gntiquement attnue. According to Camille Locht, director of the Centre Infection and immunity of Lille and coordinator aneurysm of the study Inserm which confi Metronews, "the germ of pertussis is spread through respiration. The best protection was therefore privilgier of the nasal drops instantly. We picked this germ that has been rendered harmless. Which can mimic natural infection without getting sick. "
According effectus tests, a single nasal administration was sufficient to induce an immune answer. In addition, the vaccine against pertussis prsenterait no side effects. The increase becomes inquitante limit since 2010, in some countries dvelopps as the United States, Australia, England, the Netherlands and France. aneurysm
The solution
Releases aneurysm The Conference of FAO runie Tunis underscores the need to mobilize resources in Africa / Cape Town on goal Hunger Zr 2025 Africa, youth and social inclusion
African Trust Fund: Here are the top six countries beneficiaries / A solidarity fund to support the efforts of rooting hunger and rduction malnutrition and poor
Gabon: National Foot suspended
Afrik.com / Imprint & Contact / Partners / Advertising / Affiliates / Site Map / Africa Map / Archives / News Afrik.com - 2014 - all rights r & eacu